Christie Group plc (CTG)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 166.50 |
|---|---|
| 52-week range | 87.68 – 198.21 |
| Return, 1 month / 3 months | −11.8% / +18.5% |
| Return, 1 year / 3 years | +55.4% / +81.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 30 |
| Volatility (1 year) | 42.6% |
| Worst drawdown (1 year) | -18.6% |
| Average daily value traded | 4.29M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Christie Group is a British professional services company based in London. Through its property consultancy, it advises on the sale, purchase and appraisal of businesses such as hotels, pubs, restaurants, care homes and retail outlets, acting for owners, operators and investors. Its business services arm provides stocktaking, inventory and related support to hospitality and retail clients. The company works mainly across the United Kingdom and Europe, serving clients in the hospitality, leisure, healthcare and retail markets.
On this site Christie Group plc appears as a stock on the London Exchange (UK), code CTG, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Christie Group plc (CTG) trades on the London Exchange in UK. It last closed at GBX 166.50 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 619 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 55.4% and over the last three months it rose 18.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 15.1% | ||
| From 52-week high | -13.1% | ||
| Momentum | 91 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 18.5% | ||
| 6-month return | 42.4% | ||
| 12-month return, skipping the last month | 76.1% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 42.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.6% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 4.29M GBX | ||
| Zero-volume days | 1.7% | ||
| Income | 26 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −7.5% |
|---|---|
| 1 month | −11.8% |
| 3 months | +18.5% |
| 6 months | +42.4% |
| 1 year | +55.4% |
| 3 years | +81.2% |
| 5 years | +70.6% |
Signals
| 50-day / 200-day average | 170.28 / 144.65 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.12 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Oct 2026 | GBP 0.0125 |
| 11 Jun 2026 | GBP 0.0275 |
| 9 Oct 2025 | GBP 0.0075 |
| 12 Jun 2025 | GBP 0.0175 |
| 10 Oct 2024 | GBP 0.0050 |
| 3 Oct 2024 | GBP 0.0050 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.